Annual Cash & Cash Equivalents
$3.32 M
-$3.71 M-52.82%
01 December 2023
Summary:
Dogwood Therapeutics annual cash & cash equivalents is currently $3.32 million, with the most recent change of -$3.71 million (-52.82%) on 01 December 2023. During the last 3 years, it has fallen by -$10.69 million (-76.32%).DWTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$2.04 M
-$980.40 K-32.46%
01 September 2024
Summary:
Dogwood Therapeutics quarterly cash and cash equivalents is currently $2.04 million, with the most recent change of -$980.40 thousand (-32.46%) on 01 September 2024. Over the past year, it has dropped by -$1.28 million (-38.50%).DWTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DWTX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -38.5% |
| 3 y3 years | -76.3% | -85.4% |
| 5 y5 years | +972.0% | +559.3% |
DWTX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -88.9% | -93.2% |
Dogwood Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.04 M(-32.5%) |
| June 2024 | - | $3.02 M(+26.9%) |
| Mar 2024 | - | $2.38 M(-28.3%) |
| Dec 2023 | $3.32 M(-52.8%) | $3.32 M(-30.7%) |
| Sept 2023 | - | $4.79 M(+4.3%) |
| June 2023 | - | $4.59 M(-13.9%) |
| Mar 2023 | - | $5.33 M(-24.2%) |
| Dec 2022 | $7.03 M | $7.03 M(-28.2%) |
| Sept 2022 | - | $9.79 M(+27.2%) |
| June 2022 | - | $7.70 M(-32.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $11.35 M(-19.0%) |
| Dec 2021 | $14.01 M(-53.0%) | $14.01 M(-27.0%) |
| Sept 2021 | - | $19.19 M(-12.1%) |
| June 2021 | - | $21.84 M(-11.2%) |
| Mar 2021 | - | $24.59 M(-17.5%) |
| Dec 2020 | $29.80 M(+9530.1%) | $29.80 M(+5869.8%) |
| Sept 2020 | - | $499.10 K(-52.4%) |
| June 2020 | - | $1.05 M(+238.9%) |
| Dec 2019 | $309.40 K(+931.3%) | $309.40 K |
| Dec 2018 | $30.00 K | - |
FAQ
- What is Dogwood Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dogwood Therapeutics?
- What is Dogwood Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Dogwood Therapeutics?
- What is Dogwood Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Dogwood Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of DWTX is $3.32 M
What is the all time high annual cash & cash equivalents for Dogwood Therapeutics?
Dogwood Therapeutics all-time high annual cash & cash equivalents is $29.80 M
What is Dogwood Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DWTX is $2.04 M
What is the all time high quarterly cash and cash equivalents for Dogwood Therapeutics?
Dogwood Therapeutics all-time high quarterly cash and cash equivalents is $29.80 M
What is Dogwood Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, DWTX quarterly cash and cash equivalents has changed by -$1.28 M (-38.50%)